NCT06382727

Brief Summary

Critically ill patients admitted to the Intensive Care Unit (ICU) often need to be connected to a breathing machine (ventilator) and are unable to eat. During this time, liquid nutrition is delivered via a feeding tube to the stomach or bowel (termed enteral nutrition (EN)) to ensure nutrition needs are provided until such time that the patient can eat normally. The delivery of nutrition via EN is frequently interrupted due to procedures and changes in the gastrointestinal system that can cause digestion to be slow. One of the main contributors to EN interruptions is fasting prior to removal of the breathing tube (termed extubation). The practice of pausing EN prior to the removal of the breathing tube is historical and based on evidence for patients who are not within the ICU. There is currently no scientific consensus on whether pausing of EN is necessary, or for how long. Because of this, some clinicians choose to pause EN prior to removal of the breathing tube and some clinicians continue to provide EN. This study is a pilot randomised controlled trial of fasting patients for at least 4 hours prior to removal of the breathing tube compared with not pausing EN. The investigators hypothesise that this will reduce the number of hours of fasting in the 24 hours prior to extubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

May 20, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2025

Completed
Last Updated

May 8, 2026

Status Verified

May 1, 2026

Enrollment Period

11 months

First QC Date

April 15, 2024

Last Update Submit

May 5, 2026

Conditions

Keywords

ExtubationEnteral NutritionFasting

Outcome Measures

Primary Outcomes (1)

  • Fasting time (hours)

    Fasting time due to planned extubation

    24 hours prior to endotracheal tube removal

Secondary Outcomes (9)

  • Reintubation rate

    48 hours post endotracheal tube removal

  • Days alive and free of mechanical ventilation

    Up to day 28 post randomisation

  • Commencement of antibiotics

    Up to 7 days post endotracheal tube removal

  • Ratio of oxygen saturation (SpO2)/ fraction of inspired oxygen (FiO2)

    12 hours post endotracheal tube removal

  • ICU length of stay

    Up to day 28 post randomisation

  • +4 more secondary outcomes

Study Arms (2)

Intervention group: Continuation of enteral nutrition (EN) prior to extubation

EXPERIMENTAL

Maintenance of EN at the same hourly rate until the point of extubation. Maximal suction of the EN tube prior to extubation will take place.

Other: EN will be continued up to extubation (EN will not be withheld prior to extubation)

Control group: Cessation of EN prior to extubation

NO INTERVENTION

Cessation of EN at least 4-6 hours prior to the point of extubation. Maximal suction of the EN tube prior to extubation will take place.

Interventions

As per the arm/group descriptions.

Intervention group: Continuation of enteral nutrition (EN) prior to extubation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Receiving invasive mechanical ventilation \> 24 hours and \< 10 days in the index ICU admission
  • Receiving EN at a rate ≥ 30ml/hr
  • Planned for extubation within the hours of 0800-1800

You may not qualify if:

  • EN delivery via a fine bore nasogastric tube that is unable to be aspirated
  • A single gastric residual volume ≥ the maximum protocol limit at the participating site has been recorded within the last 24 hours
  • Currently receiving extracorporeal membrane oxygenation
  • Acute neurological pathology
  • A time critical medication is required via the enteral route (including anti-parkinsons and immunosuppressant medication) and no adjustments can be made
  • Pre-existing swallow, bulbar dysfunction and/or concern around inadequate airway protection
  • A laparotomy has been performed within 72 hours of planned extubation
  • Confirmed pregnancy
  • Patient not deemed appropriate to be reintubated in the event of deterioration
  • Treating clinician believes enrolment is not in the best interests of the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Gold Coast University Hospital

Southport, Queensland, 4215, Australia

Location

St Vincent's Hospital Melbourne

Fitzroy, Victoria, 3065, Australia

Location

The Alfred Hospital

Melbourne, Victoria, 3004, Australia

Location

Related Publications (1)

  • Varghese JA, Tatucu-Babet OA, Miller E, Lambell K, Deane AM, Burrell AJC, Ridley EJ. Fasting practices of enteral nutrition delivery for airway procedures in critically ill adult patients: A scoping review. J Crit Care. 2022 Dec;72:154144. doi: 10.1016/j.jcrc.2022.154144. Epub 2022 Sep 15.

    PMID: 36115335BACKGROUND

MeSH Terms

Conditions

Critical IllnessFasting

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsFeeding BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: CONTINUE is a multi-centre, open-label, prospective parallel, pilot randomised controlled trial being conducted in Australia.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
A/Prof

Study Record Dates

First Submitted

April 15, 2024

First Posted

April 24, 2024

Study Start

May 20, 2024

Primary Completion

April 15, 2025

Study Completion

August 28, 2025

Last Updated

May 8, 2026

Record last verified: 2026-05

Locations